In this report, Technavio covers the present scenario and growth prospects of the global blood stream infection testing market for 2016-2020.The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors operating in the market. Also, the report discusses the major drivers that influence market growth, the challenges faced by vendors, and the market as a whole. It also examines key trends and their influence on current and future market scenarios.This Technavio report is based on the synthesis, nalysis, and interpretation of information about the global blood stream infection testing market collected from specialized sources. Technavio analysts have derived insights using a mix of primary and secondary research with an aim to provide a holistic picture of the market.

PART 01: Executive summary ............................................ 6

Highlights 6

PART 02: Scope of the report ............................................ 7

Market overview 7

Top-vendor offerings 8

PART 03: Market research methodology ......................... 13

Research methodology 13

Economic indicators 13

PART 04: Introduction ....................................................... 14

Key market highlights 14

PART 05: Market landscape .............................................. 17

Market overview 17

Market size and forecast 18

Five forces analysis 20

PART 06: Market segmentation by product .................... 21

Market overview 21

Instruments 22

Consumables (blood culture bottles, reagents and assay

kits) 24

PART 07: Market segmentation by application ............... 26

Bacteremia 26

Fungemia 28

Mycobacteria 29

PART 08: Market segmentation by technology ............... 30

Market overview 30

Conventional blood stream infection test 31

Point of care testing (POCT) 33

Nucleic acid testing 35

PART 09: Market segmentation by end-user ................... 37

Hospitals 37

Diagnostic clinical laboratories 37

PART 10: Geographical segmentation ............................. 39

Blood stream infection market in Americas 39

Blood stream infection tests market in EMEA 41

Blood stream infection tests market in APAC 44

PART 11: Market drivers ................................................... 46

Rising incidence of hospital acquired infection increases

patient volume 46

Patient-centered healthcare by digital technology 47

Growing awareness of blood donation increasing the

demand for BSI testing market 47

PART 12: Impact of drivers ............................................... 49

PART 13: Market challenges ............................................. 50

High cost of instruments restricts market growth 50

Lack of favorable reimbursement reduces adoption rate

among patients 50

Stringent regulatory policies restrict entry of new

technologies 51

PART 14: Impact of drivers and challenges .................... 54

PART 15: Market trends .................................................... 55

Focus on early diagnosis 55

Technologically advanced tests save time and cost 55

Increasing demand for infection control committee in

hospitals 56

PART 16: Vendor landscape ............................................. 58

Competitive scenario 58

BD 59

bioMérieux 62

Cepheid 66

Roche Diagnostics 70

Thermo Fisher Scientific 74

Other prominent vendors 78

PART 17: Appendix ........................................................... 80

List of abbreviations 80

PART 18: Explore Technavio ............................................ 81